Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The three GLP-1 medications approved by the FDA to treat obesity include: Liraglutide (Saxenda/Victoza) Semaglutide (Wegovy/Ozempic/Rybelsus) Tirzepatide (Zepbound/Mounjaro) GLP-1 medications can lead to an average weight loss of 10% to 20% over 12-24 months when used alongside healthy diet and exercise changes
It does not diagnose, treat, or prescribe
In the push for coverage, the Director of the Department of Health and Human Services (DHHS) expressed that the drugs are phenomenal and that I believe that theyre being held back from the people of North Carolinawhen they could be promoting a great deal of value here in the buckle of the Barbecue Belt. The director also explained to lawmakers that it will not cost the state more than $10 million annually because the federal government will pay for most of it
Private prescription is an alternative route, though costs can be substantial, and patients should discuss availability and costs with their prescriber or pharmacist
Heres a step-by-step look at what your journey will entail
